Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2025-12-25 @ 5:27 PM
Study NCT ID:
NCT00318604
Status:
UNKNOWN
Last Update Posted:
2006-05-12
First Post:
2006-04-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D006258', 'term': 'Head and Neck Neoplasms'}, {'id': 'D004938', 'term': 'Esophageal Neoplasms'}], 'ancestors': [{'id': 'D009371', 'term': 'Neoplasms by Site'}, {'id': 'D009369', 'term': 'Neoplasms'}, {'id': 'D005770', 'term': 'Gastrointestinal Neoplasms'}, {'id': 'D004067', 'term': 'Digestive System Neoplasms'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}, {'id': 'D004935', 'term': 'Esophageal Diseases'}, {'id': 'D005767', 'term': 'Gastrointestinal Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE'}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'NOT_YET_RECRUITING', 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2006-04', 'lastUpdateSubmitDate': '2006-05-11', 'studyFirstSubmitDate': '2006-04-25', 'studyFirstSubmitQcDate': '2006-04-25', 'lastUpdatePostDateStruct': {'date': '2006-05-12', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2006-04-27', 'type': 'ESTIMATED'}}, 'conditionsModule': {'keywords': ['plasma circulating DNA', 'hean and neck cancers', 'esophageal cancer', 'localized head and neck cancers', 'localized esophageal cancer'], 'conditions': ['Head and Neck Cancer', 'Esophageal Cancer']}, 'descriptionModule': {'briefSummary': 'This study investigates whether the amount of circulating plasma DNA can be used as a response marker for anti-cancer treatment in treating gross tumors.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '90 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Head and neck cancers\n* Esophageal cancer\n* Undergoing anti-cancer treatments\n\nExclusion Criteria:\n\n* No distant metastasis'}, 'identificationModule': {'nctId': 'NCT00318604', 'briefTitle': 'Plasma Circulating Deoxyribonucelic Acid (DNA) as a Response Marker', 'organization': {'class': 'OTHER', 'fullName': 'Far Eastern Memorial Hospital'}, 'orgStudyIdInfo': {'id': '94042'}}, 'contactsLocationsModule': {'overallOfficials': [{'name': 'LeJung Wu, MD, DPhil', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Far Eastern Memorial Hospital'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Far Eastern Memorial Hospital', 'class': 'OTHER'}}}}